United States Veterinary Dermatology Market is segmented By Drugs (Antibiotics (Convenia® (cefovecin sodium), Cephalexin (Keflex®, Rilexine®), Cefpodoxime Proxetil (Simplicef®), Clavamox (amoxicillin trihydrate/clavulanate potassium), Baytril (enrofloxacin), Clindamycin (Antirobe®, Cleocin®, ClinDrops®, Clintabs®), Lincomycin (Lincocin®), Ketoconazole (Nizoral®), Itraconazole (Itrafungol®, Sporanox®, Onmel®), Terbinafine (Lamisil®), Others), Antihistamine (Temaril-P® (trimeprazine with prednisolone)), Oclacitinib (Apoquel), Micro emulsified cyclosporine (Atopica), Cyclosporine (Neoral), Equal, Cyclavance, Lokivetmab (Cytopoint), Others), By Administration (Oral, Parenteral, Topical), By End-User (Companion Animals (Dogs, Cats, Horses, Others), Farm Animals (Poultry, Cattle, Pigs, Others)), By Distribution Channel (Veterinary Hospitals & Clinics, Pharmacies, Online Pharmacies, Others) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Report Overview
The "United States Veterinary Dermatology Market" is expected to grow at a high CAGR during the forecast period (2024-2031).
United States Veterinary Dermatology Market Summary
|
Metrics |
Details |
|
Market CAGR |
High |
|
Segments Covered |
By Drugs, By Administration , By End-User, By Distribution and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
For More Insights Request Free Sample
U.S. veterinary dermatology drugs market had a value of about USD YY Mn in 2018. It is estimated to grow to USD YY Mn by 2027, owing to rising pet ownership and adequate veterinary healthcare infrastructure availability. For instance, 62% of US households have a companion animal, equating to 72.9 million homes.
Several other demographic and socioeconomic factors have contributed to drastic changes, including livestock, food production, social attitudes, urbanization, rising adoption of companion animals are expected to boost the veterinary dermatology drugs market over the forecast period.
Growing demand for the farm animal and poultry sector is expected to boost the veterinary dermatology drugs market. Rising awareness regarding various dermatological disorders and treatment methods, favorable government initiatives to increase farm animal production are expected to create demand for the future veterinary dermatology drugs market.
Atopic dermatitis is the common cause of itching in companion animals. Atopy is a genetically determined predisposition to become allergic to airborne pollens such as weeds, grass, trees, house dust, and molds. In companion animal dogs, cat's atopic dermatitis is the most common cause of chewing, biting, rubbing, and chronic skin and ear infections. The surge in the prevalence of chronic skin disorders is anticipated to boost the market revenue size.
Based on product type, the United States market for veterinary antibiotics is broadly segmented by anti-parasitic, anti-bacterial, non-steroidal anti-inflammatory drugs.
Currently, anti-parasitic is the dominant segment, and it accounts for approximately XX% of the market due to the launch of new products and facility expansion for anti-parasitic. For instance, in January 2019, Bayer Animal Health has introduced Coraxis (moxidectin) Topical Solution for Dogs, a prescription-only, monthly transdermal product that prevents heartworm disease and treats and controls hookworms, roundworms, and whipworms in dogs. Corax is is a unique addition to the veterinarian's anti-parasite toolbox.
In June 2018, UC San Diego introduced a new center for anti-parasitic drug discovery and development to address this unmet need in global health. UC San Diego researchers use robotic technology to screen hundreds of thousands of chemical compounds from various sources, including drugs abandoned by pharmaceutical companies and marine natural products. Further, test the compounds in laboratory experiments and animal health.
The increasing use of antibiotics in livestock is one factor fueling the United States veterinary antibiotics market.
According to the Food and Drug Administration (FDA), around 12.3 million pounds of medically important antibiotics were sold for use in U.S. livestock and poultry in 2017. In the US, livestock antibiotic use accounts for about 64% of medically important antibiotics sales.
In the United States, around 80% of all antibiotics are given to cows, pigs, and chickens to make them grow more quickly or as a cheap alternative to keeping them healthy. In 2013, more than 131,000 tons of antibiotics were used in food animals worldwide, and it is expected to rise by 200,000 tons in 2030.
Why Purchase the Report?
- Visualize the veterinary dermatology market's composition across each indication regarding type and application, highlighting the critical commercial assets and players.
- Identify business opportunities in the Veterinary Dermatology market by analyzing trends and co-development deals.
- Excel data sheet with thousands of data points of the Veterinary Dermatology market-level 4/5 segmentation
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study
- Product mapping in excel for the key Veterinary Dermatology market products of all major market players.
Target Audience
- Raw Material Suppliers/ Buyers
- Product Suppliers/ Buyers
- Industry Investors/Investment Bankers
- Education & Research Institutes
- Research Professionals
- Emerging Companies
- Manufacturers
